ESMO 2023 BioNTech Data slide image

ESMO 2023 BioNTech Data

_3 BNT211 BNT211-01: Interim results from a repeat dose escalation study of CLDN6 CAR-T cells manufactured with an automated process ± a CLDN6-encoding CAR-T cell-Amplifying RNA Vaccine (CARVac) BIONTECH
View entire presentation